Opaleye Management as of Dec. 31, 2018
Portfolio Holdings for Opaleye Management
Opaleye Management holds 47 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Codexis (CDXS) | 10.9 | $29M | 1.8M | 16.70 | |
Axogen (AXGN) | 9.9 | $27M | 1.3M | 20.43 | |
Loxo Oncology | 9.2 | $25M | 175k | 140.07 | |
Amarin Corporation (AMRN) | 6.3 | $17M | 1.3M | 13.61 | |
Blueprint Medicines (BPMC) | 6.0 | $16M | 300k | 53.91 | |
Imprimis Pharmaceuticals | 3.7 | $9.8M | 1.7M | 5.69 | |
Fibrogen (FGEN) | 3.5 | $9.3M | 200k | 46.28 | |
Deciphera Pharmaceuticals (DCPH) | 2.7 | $7.1M | 340k | 20.99 | |
Epizyme | 2.6 | $6.9M | 1.1M | 6.16 | |
Ptc Therapeutics I (PTCT) | 2.4 | $6.5M | 190k | 34.32 | |
Xencor (XNCR) | 2.4 | $6.5M | 180k | 36.16 | |
Viking Therapeutics (VKTX) | 2.4 | $6.3M | 825k | 7.65 | |
Strongbridge Bioph shs usd | 2.3 | $6.2M | 1.4M | 4.48 | |
Cerecor | 2.3 | $6.2M | 2.2M | 2.84 | |
Sangamo Biosciences (SGMO) | 2.1 | $5.7M | 500k | 11.48 | |
Fennec Pharmaceuticals (FENC) | 2.1 | $5.7M | 900k | 6.38 | |
Cymabay Therapeutics | 2.1 | $5.7M | 725k | 7.87 | |
Polarityte | 2.0 | $5.4M | 400k | 13.49 | |
Audentes Therapeutics | 2.0 | $5.3M | 250k | 21.32 | |
Chimerix (CMRX) | 1.9 | $5.2M | 2.0M | 2.57 | |
Xoma Corp Del (XOMA) | 1.9 | $5.1M | 400k | 12.65 | |
ImmunoGen | 1.8 | $4.9M | 1.0M | 4.80 | |
Apellis Pharmaceuticals (APLS) | 1.4 | $3.6M | 275k | 13.19 | |
Aimmune Therapeutics | 1.3 | $3.6M | 150k | 23.92 | |
Abeona Therapeutics | 1.2 | $3.2M | 450k | 7.14 | |
Eton Pharmaceuticals (ETON) | 1.2 | $3.2M | 523k | 6.12 | |
ACADIA Pharmaceuticals (ACAD) | 1.2 | $3.2M | 195k | 16.17 | |
Tricida | 1.1 | $2.9M | 123k | 23.58 | |
Magenta Therapeutics | 1.1 | $2.9M | 505k | 5.70 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 1.1 | $2.8M | 1.2M | 2.35 | |
Avenue Therapeutics | 1.0 | $2.7M | 496k | 5.40 | |
Tg Therapeutics (TGTX) | 0.8 | $2.3M | 550k | 4.10 | |
Puma Biotechnology (PBYI) | 0.8 | $2.0M | 100k | 20.35 | |
Eidos Therapeutics | 0.7 | $1.9M | 140k | 13.76 | |
Macrogenics (MGNX) | 0.7 | $1.9M | 150k | 12.70 | |
Clementia | 0.7 | $1.8M | 150k | 11.76 | |
Zymeworks | 0.6 | $1.5M | 105k | 14.68 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.5 | $1.4M | 80k | 17.16 | |
Miragen Therapeutics | 0.4 | $1.2M | 385k | 3.03 | |
Cti Biopharma | 0.4 | $1.0M | 1.4M | 0.73 | |
Protalix BioTherapeutics | 0.3 | $775k | 2.5M | 0.31 | |
Odonate Therapeutics Ord | 0.3 | $690k | 49k | 14.08 | |
Axovant Sciences | 0.2 | $574k | 580k | 0.99 | |
Dermira | 0.2 | $539k | 75k | 7.19 | |
Assertio Therapeutics | 0.2 | $433k | 120k | 3.61 | |
ArQule | 0.1 | $358k | 200k | 1.79 | |
Biolinerx Ltd-spons | 0.0 | $110k | 250k | 0.44 |